Trials / Unknown
UnknownNCT00774332
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 37 (estimated)
- Sponsor
- Cooperative Study Group A for Hematology · Network
- Sex
- All
- Age
- 15 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Detailed description
The feasibility will be evaluated in terms of complete remission rate, duration of complete remission, disease-free survival, overall survival, and toxicities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CODOX-M | Cytoxan,Mesna,Adriamycin,Vincristine,Methotrexate,Leucovorin,Cytarabine |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2006-06-01
- Completion
- 2009-12-01
- First posted
- 2008-10-17
- Last updated
- 2008-10-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00774332. Inclusion in this directory is not an endorsement.